In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest
暂无分享,去创建一个
Takashi Ogino | Yukihiko Shirayama | Kiyohisa Takahashi | T. Ogino | Y. Shirayama | Kiyohisa Takahashi | Toshio Yano | Seizo Takahashi | Seizo Takahashi | Toshio Yano
[1] J. Rotrosen,et al. Elevated PLA2 activity in schizophrenics and other psychiatric patients , 1993, Biological Psychiatry.
[2] S. Bluml,et al. Proton‐Decoupled 31P Magnetic Resonance Spectroscopy Reveals Osmotic and Metabolic Disturbances in Human Hepatic Encephalopathy , 1998, Journal of neurochemistry.
[3] T. Inubushi,et al. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia , 1994, Psychiatry Research: Neuroimaging.
[4] D. Ingvar,et al. Distribution of cerebral activity in chronic schizophrenia. , 1974, Lancet.
[5] G B Matson,et al. P-31 MR spectroscopy of normal human brain and brain tumors. , 1990, Radiology.
[6] P. Williamson,et al. Correlation of Negative Symptoms in Schizophrenia with Frontal Lobe Parameters on Magnetic Resonance Imaging , 1991, British Journal of Psychiatry.
[7] Thomas E. Nichols,et al. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. , 1997, The American journal of psychiatry.
[8] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[9] W. Gattaz,et al. Increased platelet phospholipase A2 activity in schizophrenia , 1995, Schizophrenia Research.
[10] Robert G. Shulman,et al. Cerebral metabolism in hyper‐ and hypocarbia , 1985, Neurology.
[11] R. Khis. [Pathogenesis of schizophrenia]. , 1969, Vestnik Akademii meditsinskikh nauk SSSR.
[12] T. Brown,et al. Investigation of broad resonances in 31P NMR spectra of the human brain in vivo , 1994, NMR in biomedicine.
[13] T. Brown,et al. Free magnesium levels in normal human brain and brain tumors: 31P chemical-shift imaging measurements at 1.5 T. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Kinnunen,et al. Increased serum phospholipase A2 activity in schizophrenia: a replication study. , 1990, Biological psychiatry.
[15] P. Williamson,et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. , 1995, Archives of general psychiatry.
[16] J. Growdon,et al. Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] Heinrich Sauer,et al. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics—a study including 50 patients and 36 controls , 1998, Biological Psychiatry.
[18] P. Williamson,et al. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study , 1994, Schizophrenia Research.
[19] W. Gattaz,et al. Increased platelet membrane lysophosphatidylcholine in schizophrenia , 1991, Biological Psychiatry.
[20] G. Fein,et al. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia , 1994, Biological Psychiatry.
[21] S. Bluml,et al. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo. , 1999, Journal of computer assisted tomography.
[22] H A Krebs,et al. Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.
[23] T. Goldberg,et al. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. , 1987, Archives of general psychiatry.
[24] C. Boesch,et al. Determination of saturation factors in 31P NMR spectra of the developing human brain , 1993, Magnetic resonance in medicine.
[25] Peter Boesiger,et al. Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter , 1994, Magnetic resonance in medicine.
[26] Daniel R. Weinberger,et al. Schizophrenia and the frontal lobe , 1988, Trends in Neurosciences.
[27] T. Inubushi,et al. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia , 1995, Psychiatry Research: Neuroimaging.
[28] J. John Mann,et al. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy , 1998, Biological Psychiatry.
[29] S. Rauch,et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance , 2000, Biological Psychiatry.
[30] S Nioka,et al. Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[31] Matcheri S Keshavan,et al. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I , 2000, Biological Psychiatry.
[32] R. Shulman,et al. 31P magnetization transfer studies of creatine kinase kinetics in living rabbit brain , 1987, Magnetic resonance in medicine.
[33] M. Egan,et al. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. , 2000, The American journal of psychiatry.
[34] S Nioka,et al. Relationship between intracellular pH and energy metabolism in dog brain as measured by 31P-NMR. , 1987, Journal of applied physiology.
[35] M. Bárány,et al. INCREASED GLYCEROL-3-PHOSPHORYLCHOUNE IN POST-MORTEM ALZHEIMER'S BRAIN , 1985, The Lancet.
[36] L. Nowak,et al. Electrophysiological studies of NMDA receptors , 1987, Trends in Neurosciences.
[37] Karl J. Friston,et al. Patterns of Cerebral Blood Flow in Schizophrenia , 1992, British Journal of Psychiatry.
[38] P. Williamson,et al. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. , 1991, Archives of general psychiatry.
[39] S. Whatley,et al. Mitochondrial involvement in schizophrenia and other functional psychoses , 1996, Neurochemical Research.
[40] R. Roth,et al. Phencyclidine Model of Frontal Cortical Dysfunction in Nonhuman Primates , 2000 .
[41] P R Luyten,et al. Experimental approaches to image localized human 31P NMR spectroscopy , 1989, Magnetic resonance in medicine.
[42] G. Duncan,et al. An integrated view of pathophysiological models of schizophrenia , 1999, Brain Research Reviews.
[43] Jeffrey C. Erlich,et al. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. , 1997, Archives of general psychiatry.
[44] B. Toone,et al. Changes in regional cerebral blood flow due to cognitive activation among patients with schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.
[45] M. Keshavan,et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.
[46] T. Sigmundsson,et al. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study , 2003, Schizophrenia Research.
[47] Ravi S. Menon,et al. Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia , 2002, British Journal of Psychiatry.
[48] N C Andreasen,et al. Negative symptoms in schizophrenia , 1982 .
[49] T. Asakura,et al. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging , 1992, Acta psychiatrica Scandinavica.
[50] C. Hardy,et al. AIDS dementia complex: brain high-energy phosphate metabolite deficits. , 1990, Radiology.
[51] G. Matson,et al. Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI). , 1993, Magnetic resonance imaging.
[52] L. Cavelier,et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. , 1995, Genomics.
[53] P. Williamson,et al. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls , 1999, Biological Psychiatry.
[54] L. Horrocks,et al. Phospholipase A2 and Its Role in Brain Tissue , 1997, Journal of neurochemistry.
[55] O. Shirakawa,et al. Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia , 1999, Biological Psychiatry.
[56] H. Fukuzako,et al. Haloperidol Improves Membrane Phospholipid Abnormalities in Temporal Lobes of Schizophrenic Patients , 1999, Neuropsychopharmacology.
[57] T. Inubushi,et al. Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia , 1997, Psychiatry Research: Neuroimaging.
[58] Mathias Schreckenberger,et al. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics , 1997, The Lancet.
[59] T. Mosher,et al. Simultaneous determination of intracellular magnesium and pH from the three 31P NMR Chemical shifts of ATP. , 1993, Analytical biochemistry.
[60] S. Kish,et al. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia , 1999, Brain Research.
[61] P. Renshaw,et al. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. , 1996, The American journal of psychiatry.
[62] M. Weiner,et al. Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy , 1989 .